IL308842A - A virus-like particle vaccine for coronavirus - Google Patents
A virus-like particle vaccine for coronavirusInfo
- Publication number
- IL308842A IL308842A IL308842A IL30884223A IL308842A IL 308842 A IL308842 A IL 308842A IL 308842 A IL308842 A IL 308842A IL 30884223 A IL30884223 A IL 30884223A IL 308842 A IL308842 A IL 308842A
- Authority
- IL
- Israel
- Prior art keywords
- coronavirus
- virus
- particle vaccine
- vaccine
- particle
- Prior art date
Links
- 241000711573 Coronaviridae Species 0.000 title 1
- 108010042365 Virus-Like Particle Vaccines Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163197952P | 2021-06-07 | 2021-06-07 | |
| PCT/US2022/032201 WO2022260960A1 (en) | 2021-06-07 | 2022-06-03 | Virus-like particle vaccine for coronavirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL308842A true IL308842A (en) | 2024-01-01 |
Family
ID=84425412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL308842A IL308842A (en) | 2021-06-07 | 2022-06-03 | A virus-like particle vaccine for coronavirus |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240252621A1 (OSRAM) |
| EP (1) | EP4351638A4 (OSRAM) |
| JP (1) | JP2024520730A (OSRAM) |
| KR (1) | KR20240019213A (OSRAM) |
| CN (1) | CN118159288A (OSRAM) |
| AU (1) | AU2022289462A1 (OSRAM) |
| CA (1) | CA3221041A1 (OSRAM) |
| IL (1) | IL308842A (OSRAM) |
| MX (1) | MX2023014468A (OSRAM) |
| WO (1) | WO2022260960A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202500574A (zh) * | 2023-05-12 | 2025-01-01 | 美商伊科薩瓦克斯有限公司 | 冠狀病毒刺突醣蛋白受體結合域及其用途 |
| CN121758566A (zh) * | 2023-11-03 | 2026-03-31 | 广东蓝玉生物科技有限公司 | 非洲猪瘟病毒e248r蛋白的免疫原性组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2535421T3 (es) * | 2011-03-22 | 2015-05-11 | Mucosis B.V. | Composiciones inmunogénicas en forma particulada y métodos para producir las mismas |
| CN112521511B (zh) * | 2020-12-07 | 2023-03-14 | 中山大学 | 一种含EB病毒gB蛋白的自组装纳米颗粒及其制备方法与应用 |
-
2022
- 2022-06-03 JP JP2023574797A patent/JP2024520730A/ja active Pending
- 2022-06-03 CA CA3221041A patent/CA3221041A1/en active Pending
- 2022-06-03 KR KR1020247000038A patent/KR20240019213A/ko active Pending
- 2022-06-03 AU AU2022289462A patent/AU2022289462A1/en not_active Abandoned
- 2022-06-03 IL IL308842A patent/IL308842A/en unknown
- 2022-06-03 US US18/565,728 patent/US20240252621A1/en active Pending
- 2022-06-03 MX MX2023014468A patent/MX2023014468A/es unknown
- 2022-06-03 WO PCT/US2022/032201 patent/WO2022260960A1/en not_active Ceased
- 2022-06-03 EP EP22820815.3A patent/EP4351638A4/en active Pending
- 2022-06-03 CN CN202280055149.2A patent/CN118159288A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4351638A1 (en) | 2024-04-17 |
| WO2022260960A1 (en) | 2022-12-15 |
| CN118159288A (zh) | 2024-06-07 |
| MX2023014468A (es) | 2024-01-17 |
| AU2022289462A1 (en) | 2023-12-14 |
| EP4351638A4 (en) | 2025-05-14 |
| CA3221041A1 (en) | 2022-12-15 |
| AU2022289462A9 (en) | 2024-01-04 |
| KR20240019213A (ko) | 2024-02-14 |
| US20240252621A1 (en) | 2024-08-01 |
| JP2024520730A (ja) | 2024-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2594365B (en) | Coronavirus vaccine | |
| IL314906B2 (en) | Coronavirus vaccine | |
| GB202004974D0 (en) | Coronavirus vaccine | |
| ZA202210641B (en) | Coronavirus vaccine | |
| EP4004036A4 (en) | VIRUS-LIKE PARTICLE VACCINES | |
| GB202212336D0 (en) | Coronavirus vaccine formulations | |
| GB202217951D0 (en) | Coronavirus vaccine | |
| EP2536428A4 (en) | UNIVERSAL INFLUENZA VACCINES WITH VIRUSIC PARTICLES | |
| IL297070A (en) | Vaccine against the corona virus | |
| PL3355915T3 (pl) | Szczepionki zawierające cząstki wirusopodobne (VLP) parwowirusa psów (CPV) i ich zastosowania | |
| IL306088A (en) | Vaccine formulations against coronavirus | |
| GB201910651D0 (en) | Virus-like particle | |
| GB2620028B8 (en) | Coronavirus vaccine | |
| EP4351638A4 (en) | VACCINE WITH VIRUS-LIKE PARTICLES FOR CORONAVIRUS | |
| HK40109742A (en) | Virus-like particle vaccine for coronavirus | |
| GB202204803D0 (en) | Virus-like particles | |
| ZA202210419B (en) | Influenza virus-like particles (vlps) | |
| GB202005369D0 (en) | Virus-like particles | |
| GB202114318D0 (en) | Coronavirus Vaccines | |
| GB202103214D0 (en) | Coronavirus vaccines | |
| GB202016172D0 (en) | Coronavirus vaccine | |
| GB202101824D0 (en) | Coronavirus vaccines | |
| GB202015775D0 (en) | Coronavirus vaccines | |
| GB202004826D0 (en) | Coronavirus vaccines | |
| GB202002766D0 (en) | Coronavirus vaccines |